ASweetLife Team

Gut Cells of Mice Transformed into Insulin-Producers

The goal of a therapy for type 1 diabetes is restoration of regulated insulin secretion. A newly published study, conducted by Chutima Talchai, PhD, and Domenico Accili, MD, professor of medicine at Columbia University Medical Center...
0 Shares
Abbott logo

Abbott’s New Blood Glucose Monitoring System Receives FDA Clearance

Abbott announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients....
0 Shares

Schuhmacher Family’s Miracle

Meri Schuhmacher writes the blog Our Diabetic Life. She and her husband Ryan are the parents of fours sons, three of whom have type 1 diabetes. Right now this special family is praying for a miracle. Last month Ryan, 40, was diagnosed with cancer, and he has a giant battle to fight. Funds are being raised to help the Schuhmachers.
0 Shares

Driving Safely With Diabetes

Some people with type 1 diabetes are at an increased risk for having traffic accidents due to low blood sugar levels (hypoglycemia). A team of researchers at the University of Virginia, which has been conducting diabetes research studies funded by NIH for the past 25 years, is now conducting a study with the hope of helping the diabetes community drive safely.
0 Shares
Medtronic - logo

Low Glucose Suspend Feature Proves Effective in Controlling Hypoglycemia

Medtronic has announced that the results of the in-clinic ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) study met its efficacy endpoints and showed a 19% reduction in time spent below the low glucose threshold in patients using the MiniMed Paradigm System featuring Low Glucose Suspend automation, compared...
0 Shares
mass General Hospital logo

Beta Cells May Function Years After Type 1 Diabetes Diagnosis

A study conducted at Massachusetts General Hospital (MGH) has found that insulin production may persist for decades after the onset of type 1 diabetes. In the study, led by Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory, blood samples from 182 individuals with type 1 diabetes were evaluated
0 Shares
sanofi-logo

Sanofi’s Data Design Diabetes Innovation Challenge Launched

Sanofi US has launched its Data Design Diabetes Innovation Challenge and is accepting entries. The Innovation Challenge is aligned with the United States government's initiative to use an open dialogue to drive action toward a three-part aim: innovation in the quality, delivery and cost of diabetes care...
0 Shares

LifeScan Recalls OneTouch Verio IQ Glucose Meters

Life Scan has announced the voluntary recall of their OneTouch Verio IQ Meter. The reason given by LifeScan for the recall of the glucose meter is that under very specific circumstances the OneTouch Verio IQ Meter produces an error that causes the meter to turn itself off when a user attempts to access...
0 Shares